Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
1.190
-0.010 (-0.83%)
Nov 21, 2024, 4:00 PM EST - Market closed

Spero Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2015
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2015
Net Income
3.5122.81-46.42-89.76-78.28-60.93
Upgrade
Depreciation & Amortization
0.040.370.870.650.760.75
Upgrade
Loss (Gain) From Sale of Assets
-----0.18
Upgrade
Asset Writedown & Restructuring Costs
-5.310.64---
Upgrade
Loss (Gain) From Sale of Investments
--0.010.25-0.03-0.75
Upgrade
Stock-Based Compensation
8.297.939.129.434.893.78
Upgrade
Other Operating Activities
1.020.975.962.220.260.17
Upgrade
Change in Accounts Receivable
-50.29-96.21.553.052.43-7.38
Upgrade
Change in Accounts Payable
4.990.76-0.48-0.05-2.980.56
Upgrade
Change in Unearned Revenue
5.8829.0121.8910.64--
Upgrade
Change in Income Taxes
-2.110.39-0.78-0.250.3
Upgrade
Change in Other Net Operating Assets
11.14-4.33-0.87-1.56-12.6713.3
Upgrade
Operating Cash Flow
-17.54-33-7.73-64.35-85.87-50.02
Upgrade
Capital Expenditures
-----0.16-0.31
Upgrade
Sale of Property, Plant & Equipment
---0.04--
Upgrade
Investment in Securities
--33.817.6310.6329.84
Upgrade
Investing Cash Flow
--33.817.6710.4729.53
Upgrade
Issuance of Common Stock
00.2224.9336.8280.8516.3
Upgrade
Other Financing Activities
---54.4947.23-0.95-0.16
Upgrade
Financing Cash Flow
00.22-29.5584.05130.8816.14
Upgrade
Net Cash Flow
-17.54-32.77-3.4827.3855.48-4.35
Upgrade
Free Cash Flow
-17.54-33-7.73-64.35-86.03-50.33
Upgrade
Free Cash Flow Margin
-16.47%-31.79%-14.45%-352.47%-922.07%-277.37%
Upgrade
Free Cash Flow Per Share
-0.33-0.62-0.21-2.08-3.84-2.77
Upgrade
Cash Income Tax Paid
2.212.21----
Upgrade
Levered Free Cash Flow
-16.05-9.9-1.08-41.44-55.16-26.47
Upgrade
Unlevered Free Cash Flow
-16.05-9.90.55-40.22-55.16-26.47
Upgrade
Change in Net Working Capital
23.3334.94-9.66-4.6811.21-8.82
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.